Japan-based drugmaker Eisai Co's U.S. subsidiary announced on Sunday that it had received approval from the U.S. Food and Drug Administration for its insomnia treatment in adult patients.
The U.S. Food and Drug Administration has approved Intra-Cellular Therapies Inc's investigational drug to treat schizophrenia, the company said on Monday.
NMC Health has launched an independent review of its books, seeking to reassure investors after U.S. short-selling firm Muddy Waters last week questioned the healthcare group's finances.
Ram Dass, who in the 1960s joined Timothy Leary in promoting psychedelic drugs as the path to inner enlightenment before undergoing a spiritual rebirth he spelled out in the influential book "Be Here Now," died at home on Sunday. He was 88 years old.
An unmarried Chinese woman filed a suit against a hospital on Monday for rejecting her request to undergo a medical procedure to freeze her eggs due to her marital status, in China's first legal challenge of a woman fighting for her reproductive rights.
Roche entered into a $1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta's investigational gene therapy for Duchenne muscular dystrophy (DMD) outside the United States.
Israel's IceCure Medical said on Sunday it received U.S. regulatory approval to expand the use of its cryoablation technology to treat benign and cancerous tumors in livers and kidneys, sending its share price up 30%.
The U.S. Environmental Protection Agency and the Justice Department said a federal appeals court should reverse a lower court verdict finding Bayer AG liable in the case of a California man who blamed its Roundup weed killer for his cancer.
GlaxoSmithKline's HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.
(Reuters Health) - Nearly 85% of toddlers and infants in the United States eat foods containing added sugars and artificial sweeteners on any given day, researchers say.
Merck & Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries.
Related Videos
Introducing the all-new Reuters News app
The new Reuters News app is here, redesigned from the ground up to fit your busy life.
